McKesson Co. (NYSE:MCK) Shares Purchased by Mutual Advisors LLC

Mutual Advisors LLC boosted its position in McKesson Co. (NYSE:MCK) by 21.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,220 shares of the company’s stock after purchasing an additional 212 shares during the period. Mutual Advisors LLC’s holdings in McKesson were worth $565,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Legacy Financial Group LLC acquired a new stake in McKesson in the third quarter worth approximately $27,000. OFI Invest Asset Management bought a new position in shares of McKesson in the third quarter valued at $26,000. BKM Wealth Management LLC bought a new position in shares of McKesson in the fourth quarter valued at $31,000. Live Oak Investment Partners bought a new position in shares of McKesson in the fourth quarter valued at $30,000. Finally, Covestor Ltd increased its holdings in shares of McKesson by 72.3% in the first quarter. Covestor Ltd now owns 81 shares of the company’s stock valued at $25,000 after buying an additional 34 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on MCK shares. Leerink Partnrs reaffirmed an “outperform” rating on shares of McKesson in a report on Monday, February 26th. StockNews.com cut McKesson from a “strong-buy” rating to a “buy” rating in a report on Thursday, January 4th. Wells Fargo & Company started coverage on McKesson in a report on Thursday, December 14th. They issued an “equal weight” rating and a $502.00 price target on the stock. TD Cowen upped their price target on McKesson from $508.00 to $563.00 and gave the company an “outperform” rating in a report on Monday, December 11th. Finally, UBS Group boosted their target price on shares of McKesson from $575.00 to $620.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $522.21.

McKesson Trading Up 0.6 %

NYSE MCK opened at $539.51 on Thursday. McKesson Co. has a 1-year low of $349.66 and a 1-year high of $539.99. The company has a market capitalization of $70.90 billion, a PE ratio of 24.45, a price-to-earnings-growth ratio of 1.62 and a beta of 0.44. The firm’s fifty day simple moving average is $511.92 and its 200-day simple moving average is $474.70.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $7.74 earnings per share for the quarter, topping analysts’ consensus estimates of $7.05 by $0.69. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The business had revenue of $80.90 billion for the quarter, compared to the consensus estimate of $77.93 billion. During the same period in the prior year, the business posted $6.90 earnings per share. McKesson’s revenue for the quarter was up 14.8% compared to the same quarter last year. As a group, analysts predict that McKesson Co. will post 27.61 EPS for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, April 1st. Stockholders of record on Friday, March 1st will be paid a $0.62 dividend. This represents a $2.48 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date of this dividend is Thursday, February 29th. McKesson’s dividend payout ratio (DPR) is presently 11.24%.

Insider Buying and Selling

In related news, EVP Leann B. Smith sold 186 shares of the company’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the sale, the executive vice president now directly owns 1,511 shares in the company, valued at $749,456. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other McKesson news, CEO Brian S. Tyler sold 3,473 shares of the company’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the sale, the chief executive officer now directly owns 43,445 shares in the company, valued at $22,789,074.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Leann B. Smith sold 186 shares of the company’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total transaction of $92,256.00. Following the sale, the executive vice president now owns 1,511 shares of the company’s stock, valued at $749,456. The disclosure for this sale can be found here. Over the last three months, insiders sold 17,685 shares of company stock worth $8,646,498. Corporate insiders own 0.21% of the company’s stock.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.